Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
LifeMine Therapeutics is a science-driven biopharmaceutical company focused on discovering, developing, and commercializing transformative medicines by mining genetically-encoded small molecules (GEMs) from the biosphere, with an initial focus on fungi. Utilizing its proprietary Avatar™ platform, which integrates genomics, data science, synthetic biology, and AI, LifeMine aims to unlock nature's evolutionary wisdom to find drug candidates with inherently good pharmacological properties for treating intractable human diseases, including cancer, immune disorders, and rare diseases.
The Cambridge headquarters serves as the central hub for LifeMine's research, drug discovery and development operations, corporate strategy, and houses its advanced Avatar™ platform laboratories.
State-of-the-art laboratories for genomics, synthetic biology, high-throughput screening, and medicinal chemistry, situated within the dynamic Kendall Square biotech ecosystem.
LifeMine fosters a scientifically driven, innovative, and collaborative work culture. Located in Kendall Square, employees are part of a vibrant biotech ecosystem, encouraging continuous learning and groundbreaking discoveries in drug development. The company emphasizes curiosity, rigor, and a shared commitment to advancing medicine.
Its strategic location in Kendall Square provides unparalleled access to world-class talent, leading academic and research institutions, and numerous collaboration opportunities, fostering innovation and growth.
While its physical headquarters and primary operations are based in Cambridge, MA, LifeMine Therapeutics's drug discovery efforts have a global scope. The company's search for novel genetically-encoded small molecules (GEMs) from fungi involves exploring diverse biological sources from around the world. LifeMine aims to address unmet medical needs globally with its innovative therapeutics, and may engage in international collaborations for research, clinical trials, and future commercialization.
245 Main Street
Cambridge
MA
USA
Address: N/A
N/A
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, LifeMine Therapeutics' leadership includes:
LifeMine Therapeutics has been backed by several prominent investors over the years, including:
LifeMine Therapeutics has significantly strengthened its executive leadership over the past 12 months with strategic C-suite appointments, including a new Chief Financial Officer and a new Chief Product and Strategy Officer, to drive its next phase of growth and drug development.
Discover the tools LifeMine Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
LifeMine Therapeutics commonly uses an email format that combines the first initial of an employee's first name with their full last name, followed by the domain '@lifeminetx.com'. This is a prevalent pattern within the company.
[first_initial][last]@lifeminetx.com
Format
gverdine@lifeminetx.com
Example
85%
Success rate
Fierce Biotech • May 20, 2024
LifeMine Therapeutics announced the appointment of Priya Bhardwaj, Ph.D., to the newly created position of Chief Product and Strategy Officer. Dr. Bhardwaj will be responsible for leading and integrating product development functions as well as corporate strategy, bringing experience from roles at Juno Therapeutics and Roche....more
PR Newswire • November 28, 2023
LifeMine Therapeutics today announced the appointment of Donald R. Kania, Jr., J.D., as Chief Financial Officer. Mr. Kania brings over 20 years of experience in finance and capital markets within the biopharmaceutical industry to support LifeMine's financial strategy and growth....more
GlobeNewswire • January 9, 2024
LifeMine Therapeutics announced its participation and presentation at the 42nd Annual J.P. Morgan Healthcare Conference, a key event for investors and industry leaders. This provided an update on the company's progress and strategic direction....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including LifeMine Therapeutics, are just a search away.